http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1268168-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1a6be486c6c3a976fdaa42fd973b106 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-095 |
| filingDate | 1982-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1986-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f25b082fd2b731956118ac721548ebb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7656be5d6eb9acf5a66b3393fa51b57e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e575dc8dbc6849ced64164fa104ced0 |
| publicationDate | 1986-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1268168-A1 |
| titleOfInvention | Method of treatment of destructive pulmonary tuberculosis |
| abstract | This invention relates to medicine and is intended for the treatment of pulmonary pulmonary tuberculosis. The purpose of the invention is to reduce the duration of treatment and increase the percentage of closure of the decay cavities. Tuberculostatic drugs are prescribed to the patient and additionally 5% unithiol is administered daily at 5 mp. Bacteriolysis ceases after 1-2 months. With an x-ray tomography after 2-5 months, closure of the decay cavities and the almost complete resorption of inflammatory changes are observed. (Ls |
| priorityDate | 1982-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.